title: [Palliative treatment of rectal cancer by the trans-anal approach using a urologic prostatectomy device].
abstract: Palliative treatment for patients with rectal carcinoma affect more than 10% of the 8000 cases diagnosed each year in France. Twenty-four patients underwent endoscopic trans-anal resection using a urological resectoscope. The morbidity rate was 18,5% and there were no postoperative deaths. The median hospital stay for the procedure alone was 4 days. Good palliation was obtained in 89% of cases. This simple, minimally invasive and economic method should join palliative treatment for patients with rectal carcinoma beside laser destruction and external beam radiotherapy.
authors.affiliation: Service de Chirurgie viscérale, CHU Angers.
authors.forename: J P
authors.initials: JP
authors.lastname: Arnaud
authors.forename: B
authors.initials: B
authors.lastname: Debras
authors.forename: G
authors.initials: G
authors.lastname: Becouarn
authors.forename: D
authors.initials: D
authors.lastname: Chautard
authors.forename: C
authors.initials: C
authors.lastname: Casa
mesh_terms: D000230:Adenocarcinoma / Q000601:surgery*; D000368:Aged; D000369:Aged, 80 and over; D004564:Electrocoagulation / Q000295:instrumentation*; D004724:Endoscopy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010166:Palliative Care; D011468:Prostatectomy / Q000295:instrumentation; D012004:Rectal Neoplasms / Q000601:surgery*
vernacular_title: Traitement palliatif des cancers du rectum par voie trans-anale à l'aide du résecteur urologique à prostate.